Naloxon OrPha
Naloxon OrPha is a medicine authorised by Swissmedic under authorisation number 56952. The authorisation holder is OrPha Swiss GmbH. The medicinal product code is Antidotes and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 June 2004 and the authorisation is valid without a time limit. ATC code V03AB15 places the medicine in the group All other therapeutic products.
| Authorisation number | 56952 |
|---|---|
| Name | Naloxon OrPha |
| Full name | Naloxon OrPha, Injektionslösung |
| Authorisation holder | OrPha Swiss GmbH |
| Medicinal product code | Antidotes |
| Dispensing category | B · Prescription only |
| ATC code | V03AB15 |
| First authorisation | 07 June 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Naloxon OrPha, Injektionslösung | B | 07 June 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Ampulle(n) | V03AB15 | 15.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Naloxon OrPha authorised in Switzerland?
Yes. Naloxon OrPha is authorised by Swissmedic under authorisation number 56952, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Naloxon OrPha have?
Naloxon OrPha is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Naloxon OrPha?
The authorisation holder is OrPha Swiss GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.